Induction of interferon-γ from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon-α and tumour necrosis factor-α

被引:66
|
作者
Marshall, JD [1 ]
Heeke, DS [1 ]
Abbate, C [1 ]
Yee, P [1 ]
Van Nest, G [1 ]
机构
[1] Dynavax Technol Corp, Berkeley, CA 94710 USA
关键词
CpG DNA; interferon-alpha; interferon-gamma; natural killer cells; plasmacytoid dendritic cells;
D O I
10.1111/j.1365-2567.2005.02261.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunostimulatory sequences (ISS) that contain CpG motifs have been demonstrated to exert antipathogen and antitumour immunity in animal models through several mechanisms, including the activation of natural killer (NK) cells to secrete interferon-gamma (IFN-gamma) and to exert lytic activity. Since NK cells lack the ISS receptor TLR9, the exact pathway by which NK cells are activated by ISS is unclear. We determined that ISS-induced IFN-gamma from NK cells is primarily dependent upon IFN-alpha release from plasmacytoid dendritic cells (PDCs), which directly activates the NK cell. However, further analysis indicated that other PDC-released soluble factor(s) may contribute to IFN-gamma induction. Indeed, tumour necrosis factor-alpha (TNF-alpha) was identified as a significant contributor to ISS-mediated activation of NK cells and was observed to act in an additive fashion with IFN-alpha in the induction of IFN-gamma from NK cells and to up-regulate CD69 expression on NK cells. This activity of TNF-alpha, however, was dependent upon the presence of PDC-derived factors such as type I interferon. These results illustrate an important function for type I interferon in innate immunity, which is not only to activate effectors like NK cells directly, but also to prime them for enhanced activation by other factors such as TNF-alpha.
引用
收藏
页码:38 / 46
页数:9
相关论文
共 50 条
  • [21] Interleukin-15 and interferon-γ participate in the cross-talk between natural killer and monocytic cells required for tumour necrosis factor production
    Gonzalez-Alvaro, Isidoro
    Dominguez-Jimenez, Carmen
    Ortiz, Ana M.
    Nunez-Gonzalez, Vanessa
    Roda-Navarro, Pedro
    Fernandez-Ruiz, Elena
    Sancho, David
    Sanchez-Madrid, Francisco
    ARTHRITIS RESEARCH & THERAPY, 2006, 8 (04)
  • [22] IL-21 enhances dendritic cell ability to induce interferon-γ production by natural killer T cells
    Maeda, Masanori
    Yanagawa, Yoshiki
    Iwabuchi, Kazuya
    Minami, Keita
    Nakamaru, Yuji
    Takagi, Dai
    Fukuda, Satoshi
    Onoe, Kazunori
    IMMUNOBIOLOGY, 2007, 212 (07) : 537 - 547
  • [23] Tumour necrosis factor-α and interferon-γ synergistically activate the RANTES promoter through nuclear factor κB and interferon regulatory factor 1 (IRF-1) transcription factors
    Lee, AH
    Hong, JH
    Seo, YS
    BIOCHEMICAL JOURNAL, 2000, 350 : 131 - 138
  • [24] Differential effects of lipoprotein lipase on tumor necrosis factor-α and interferon-γ-mediated gene expression in human endothelial cells
    Kota, RS
    Ramana, CV
    Tenorio, FA
    Enelow, RI
    Rutledge, JC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (35) : 31076 - 31084
  • [25] Plasmacytoid Dendritic Cells (pDCs) From HIV Controllers Produce Interferon-α and Differentiate Into Functional Killer pDCs Under HIV Activation
    Barblu, Lucie
    Machmach, Kawthar
    Gras, Christophe
    Delfraissy, Jean-Francois
    Boufassa, Faroudy
    Leal, Manuel
    Ruiz-Mateos, Ezequiel
    Lambotte, Olivier
    Herbeuval, Jean-Philippe
    JOURNAL OF INFECTIOUS DISEASES, 2012, 206 (05): : 790 - 801
  • [26] Deficiency of tumour necrosis factor-α and interferon-γ in bone marrow cells synergistically inhibits neointimal formation following vascular injury
    Murayama, Hideki
    Takahashi, Masafumi
    Takamoto, Masaya
    Shiba, Yuji
    Ise, Hirohiko
    Koyama, Jun
    Tagawa, Yoh-ichi
    Iwakura, Yoichiro
    Ikeda, Uichi
    CARDIOVASCULAR RESEARCH, 2008, 80 (02) : 175 - 180
  • [27] Clinical applicability of T-cell interferon-α release assay for tumour necrosis factor-α inhibitor therapy in severe psoriasis
    Chiang, Y. Z.
    Panting, K.
    Dever, B.
    Parslew, R. A. G.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2011, 36 (01) : 39 - 41
  • [28] Dendritic cell-derived interferon-γ-induced protein mediates tumor necrosis factor-α stimulation of human lung fibroblasts
    Liao, Wupeng
    Bao, Zhang
    Cheng, Chang
    Mok, Yu-Keung
    Wong, W. S. Fred
    PROTEOMICS, 2008, 8 (13) : 2640 - 2650
  • [29] Effects of interferon-γ and tumour necrosis factor-α on CD95/Fas ligand-mediated apoptosis in human blood eosinophils
    Luttmann, W
    Dauer, E
    Schmidt, S
    Marx, O
    Hossfeld, M
    Matthys, H
    Virchow, JC
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2000, 51 (01) : 54 - 59
  • [30] Cytokines Tumor Necrosis Factor-α and Interferon-γ Induce Pancreatic β-Cell Apoptosis through STAT1-mediated Bim Protein Activation
    Barthson, Jenny
    Germano, Carla M.
    Moore, Fabrice
    Maida, Adriano
    Drucker, Daniel J.
    Marchetti, Piero
    Gysemans, Conny
    Mathieu, Chantal
    Nunez, Gabriel
    Jurisicova, Andrea
    Eizirik, Decio L.
    Gurzov, Esteban N.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (45) : 39632 - 39643